News | Health & Safety
23 Oct 2017 20:46
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Ski Report
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     23 Oct: Rosemary Leach dies aged 81 after short illness
     22 Oct: NZ hospital spurns Ronald McDonald
     21 Oct: Woman charged over Auckland stabbing
     21 Oct: Mental health a top priority in Canterbury
     20 Oct: Shares rise as weak dollar helps companies
     20 Oct: More drinking fountains to tackle obesity
     17 Oct: Mums reminded about iodine, folic acid
     Top Stories

    RUGBY RUGBY
    Retallick given time to return: Hansen More...


    BUSINESS BUSINESS
    Vocus aims to sell NZ business by June More...



     Today's News

    International:
    It's a rare day when George W Bush and Barack Obama agree: the American creed is in trouble 19:57

    Sports:
    King battles into New York squash final 19:27

    Environment:
    David Attenborough urges global action to reduce plastic in oceans 19:07

    Law and Order:
    Man arrested over Greymouth shooting death 17:57

    Rugby League:
    Meninga faces tough No.6 call: Gillett 17:17

    Sailing:
    Vestas early leader in Volvo Ocean Race 16:57

    International:
    James Toback: Who is the latest Hollywood mogul accused of sexual harassment? 16:37

    Rugby:
    Retallick given time to return: Hansen 15:17

    Motorsports:
    Kiwi Hartley 13th in Formula One debut 15:07

    Basketball:
    Adams shines in NBA loss for Oklahoma City 15:07


     News Search






    Power Search


    © 2017 New Zealand City Ltd